Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
231
-
Total 13F shares, excl. options
-
51.3M
-
Shares change
-
+668K
-
Total reported value, excl. options
-
$1.22B
-
Value change
-
+$7.79M
-
Put/Call ratio
-
0.39
-
Number of buys
-
104
-
Number of sells
-
-119
-
Price
-
$23.72
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q4 2019
274 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2019.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 231 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.3M shares
of 56M outstanding shares and own 91.54% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.73M shares), VANGUARD GROUP INC (5.31M shares), ARMISTICE CAPITAL, LLC (1.71M shares), STATE STREET CORP (1.68M shares), DIMENSIONAL FUND ADVISORS LP (1.66M shares), MACQUARIE GROUP LTD (1.51M shares), MORGAN STANLEY (1.07M shares), Invesco Ltd. (1.04M shares), RICE HALL JAMES & ASSOCIATES, LLC (962K shares), and RENAISSANCE TECHNOLOGIES LLC (921K shares).
This table shows the top 231 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.